Date | Insider | Price | Amount |
---|---|---|---|
5-1-2020 Insider Buy |
Avoro Capital Advisors LLC Director and >10% Owner |
$28.50 CAGR » |
$49,875,000.00 1,750,000 shares |
12-5-2019 Insider Buy |
Avoro Capital Advisors LLC Director and >10% Owner |
$17.50 CAGR » |
$35,000,000.00 2,000,000 shares |
10-3-2019 Insider Buy |
Bryan Ball Chief Quality Officer |
$14.18 CAGR » |
$70,896.50 5,000 shares |
10-3-2019 Insider Buy |
Avoro Capital Advisors LLC Director and >10% Owner |
$13.52 CAGR » |
$20,280,000.00 1,500,000 shares |
6-28-2019 Insider Buy |
Avoro Capital Advisors LLC Director and >10% Owner |
$13.55 CAGR » |
$13,548,000.00 1,000,000 shares |
6-20-2019 Insider Buy |
Bryan Ball Chief Quality Officer |
$13.35 CAGR » |
$66,750.00 5,000 shares |
6-5-2019 Insider Buy |
Avoro Capital Advisors LLC Director and >10% Owner |
$12.21 CAGR » |
$18,743,220.41 1,535,539 shares |
5-15-2019 Insider Buy |
Avoro Capital Advisors LLC Director |
$15.11 CAGR » |
$11,328,750.00 750,000 shares |
6-15-2018 Insider Buy |
venBio Select Advisor LLC Director and >10% Owner |
$23.39 CAGR » |
$4,678,000.00 200,000 shares |
6-15-2018 Insider Buy |
venBio Select Advisor LLC Director and >10% Owner |
$24.00 CAGR » |
$13,800,000.00 575,000 shares |
11-15-2017 Insider Buy |
venBio Select Advisor LLC Director and >10% Owner |
$10.47 CAGR » |
$13,868,250.00 1,325,000 shares |
11-15-2017 Insider Buy |
Behzad Aghazadeh Director and >10% Owner |
$10.47 CAGR » |
$13,868,250.00 1,325,000 shares |
3-5-2009 Insider Buy |
David M. Goldenberg CSO, CMO and Chairman |
$0.91 CAGR » |
$27,265.00 30,000 shares |
3-5-2009 Insider Buy |
Cynthia L. Goldenberg President and CEO |
$0.91 CAGR » |
$27,265.00 30,000 shares |
9-19-2008 Insider Buy |
Cynthia L. Goldenberg President and CEO |
$2.00 CAGR » |
$299,816.00 150,000 shares |
Also See: Institutional Holders of IMMU
Also See: SEC filings
Growth of $10,000.00 Without Dividends Reinvested |
||
Start date: | 05/04/2020 | |
End date: | 10/23/2020 | |
Start price/share: | $31.68 | |
End price/share: | $87.86 | |
Dividends collected/share: | $0.00 | |
Total return: | 177.34% | |
Annualized Gain: | 376.32% | |
Starting investment: | $10,000.00 | |
Ending investment: | $27,734.00 | |
Years: | 0.47 |
Immunomedics Insider Buying
This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.), and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these categories, but instead file their holdings quarterly on the latest form 13F filings. While recent Immunomedics insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).
Also See: Funds Holding IMMU
Free IMMU Email Alerts: Get Dividend Alerts Get SEC Filing Alerts |